255 related articles for article (PubMed ID: 19664641)
1. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
Zhang HS; Sang WW; Wang YO; Liu W
J Cell Biochem; 2010 Aug; 110(6):1464-70. PubMed ID: 20506278
[TBL] [Abstract][Full Text] [Related]
3. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
Zhang HS; Wu MR
Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
[TBL] [Abstract][Full Text] [Related]
4. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
Zhang HS; Wu TC; Sang WW; Ruan Z
Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
Zhang HS; Chen XY; Wu TC; Zhang FJ
J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
[TBL] [Abstract][Full Text] [Related]
6. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Zhang HS; Sang WW; Ruan Z; Wang YO
Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
[TBL] [Abstract][Full Text] [Related]
8. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway.
Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z
FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739
[TBL] [Abstract][Full Text] [Related]
9. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
Zhang HS; Ruan Z; Sang WW
J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 regulates HIV transcription via Tat deacetylation.
Pagans S; Pedal A; North BJ; Kaehlcke K; Marshall BL; Dorr A; Hetzer-Egger C; Henklein P; Frye R; McBurney MW; Hruby H; Jung M; Verdin E; Ott M
PLoS Biol; 2005 Feb; 3(2):e41. PubMed ID: 15719057
[TBL] [Abstract][Full Text] [Related]
11. MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1.
Zhang HS; Wu TC; Sang WW; Ruan Z
Biochim Biophys Acta; 2012 May; 1823(5):1017-23. PubMed ID: 22406815
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
[TBL] [Abstract][Full Text] [Related]
13. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
Chande AG; Baba M; Mukhopadhyaya R
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 replication is inhibited by a pseudo-substrate peptide that blocks Tat transactivation.
Okamoto H; Cujec TP; Peterlin BM; Okamoto T
Virology; 2000 May; 270(2):337-44. PubMed ID: 10792993
[TBL] [Abstract][Full Text] [Related]
15. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.
Zauli G; La Placa M; Vignoli M; Re MC; Gibellini D; Furlini G; Milani D; Marchisio M; Mazzoni M; Capitani S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):306-16. PubMed ID: 7552492
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties.
Demirhan I; Chandra A; Sarin PS; Hasselmayer O; Hofmann D; Chandra P
Anticancer Res; 2000; 20(4):2513-7. PubMed ID: 10953320
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of SIRT1 by HIV-1 viral protein Tat results in activation of p53 pathway.
Thakur BK; Chandra A; Dittrich T; Welte K; Chandra P
Biochem Biophys Res Commun; 2012 Jul; 424(2):245-50. PubMed ID: 22732402
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.
Jiang MC; Lin JK; Chen SS
Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
Endo-Munoz L; Warby T; Harrich D; McMillan NA
Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation.
Khan N; Datta G; Geiger JD; Chen X
J Neuroinflammation; 2018 Mar; 15(1):91. PubMed ID: 29558961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
